MedTrace Logo

Immunomodulatory Effect of Macrolides in Naturally Occurring Influenza Virus Infections in the Community

NCT03824847 · Status: SUSPENDED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-11-04

No results posted yet for this study

Summary

The investigators propose a double-blind randomised placebo-controlled study in naturally occurring influenza virus infections in the community setting to compare the impact of a short course of clarithromycin versus placebo, on the clinical course, viral shedding, immunomodulation, and the antimicrobial resistance pattern of respiratory bacterial carriage of the patients.

Conditions

  • Influenza, Human

Interventions

DRUG

Clarithromycin 250 MG

Clarithromycin 1 tablet (250mg) twice daily for three days

DRUG

Placebos

Placebo group: (identical-looking) placebo 1 tablet twice daily for three days

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Dennis KM Ip, MD · School of Public Health, The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-03-01
Completion
2024-09-01

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03824847 on ClinicalTrials.gov